COMMUNIQUÉS West-GlobeNewswire

CareDx Welcomes Initiatives from US Government to Support Transplant Care
05/03/2019
CMS initiative “Patients over Paperwork” aims to increase organ availability BRISBANE, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, [...]
Minerva Neurosciences to Report Fiscal 2018 Fourth Quarter and Year End Financial Results and Business Updates on March 12, 2019
05/03/2019
Management to host conference call WALTHAM, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to [...]
Outlook Therapeutics Regains Compliance With All Nasdaq Listing Requirements
05/03/2019
CRANBURY, N.J., March 05, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK) (the “Company”) announced today that the Company received formal notice from The Nasdaq Stock Market LLC that the Company has [...]
Passage Bio to Present at the Cowen and Company 39th Annual Health Care Conference
05/03/2019
PHILADELPHIA, March 05, 2019 (GLOBE NEWSWIRE) -- Passage Bio, a genetic medicines company developing AAV-delivered therapeutics for the treatment of rare monogenic central nervous system diseases, today announced that [...]
UAHC Subsidiary American Sustainable Rubber Company, LLC Garners Coverage in International Business Times & This Giant Beast That is the Global Economy
05/03/2019
CHICAGO, March 05, 2019 (GLOBE NEWSWIRE) -- United American Healthcare Corporation (OTC: UAHC), an emerging technology holding company, today announced its wholly-owned subsidiary American Sustainable Rubber Company, [...]
Silicon Valley TMS Now Offering Cutting Edge Mental Health Technology for Obsessive-Compulsive Disorder (OCD) in Northern California
05/03/2019
Deep Transcranial Magnetic Stimulation (Deep TMS) therapy poised to make an impact for patients living with OCD as facility expands its treatment options SAN JOSE, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Silicon [...]
Intra-Cellular Therapies to Present at The Cowen and Company 39th Annual Health Care Conference
05/03/2019
NEW YORK, March 05, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
Daré Bioscience, Inc. to Present at the Cowen 39th Annual Healthcare Conference
05/03/2019
SAN DIEGO, March 05, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Johnson, President and Chief Executive Officer, will present at the [...]
Kezar Life Sciences to Present at the Cowen and Company 39th Annual Health Care Conference
05/03/2019
SOUTH SAN FRANCISCO, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet [...]
Allena Pharmaceuticals, Inc. to Present at 39th Annual Cowen & Co. Health Care Conference
05/03/2019
NEWTON, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics [...]
Inhibikase Therapeutics Appoints Leading Experts in Parkinson’s Disease to its Scientific Advisory Board
05/03/2019
ATLANTA and BOSTON, March 05, 2019 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc., a pharmaceutical company developing protein kinase inhibitors for the treatment of neurological infections and neurodegenerative [...]
Melinta Therapeutics to Report Fourth Quarter and Year-End 2018 Financial Results on March 13, 2019
05/03/2019
MORRISTOWN, N.J., March 05, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial [...]
Profound Medical to Present at the Cowen and Company 39th Annual Health Care Conference
05/03/2019
TORONTO, March 05, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that combines real-time Magnetic Resonance (“ [...]
Continued ICP Orders From Japanese Customers
05/03/2019
Asian market shows potential for Precipio’s proprietary liquid biopsy technology NEW HAVEN, Conn., March 05, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced today that [...]
Amedisys to Present at 29th Annual Oppenheimer Healthcare Conference
05/03/2019
BATON ROUGE, La., March 05, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, today announced that Paul B. Kusserow, President and [...]
Marinus Pharmaceuticals to Present at the Cowen Healthcare Conference
05/03/2019
RADNOR, Pa., March 05, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and [...]
Kura Oncology Announces FDA Clearance of Investigational New Drug Application for Menin-MLL Inhibitor KO-539
05/03/2019
– KO-539 is a potent, selective small molecule inhibitor of the menin-MLL interaction – – Robust anti-tumor activity observed in mixed lineage leukemias rearranged and oncogenic driver mutations in genes such as NPM1 [...]
FSD Pharma's Investments Provide Unique Diversification -- CFN Media
05/03/2019
SEATTLE, March 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of [...]
Otonomy to Participate in Two Upcoming Investor Conferences
05/03/2019
SAN DIEGO, March 05, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that David A. Weber, Ph.D [...]

Pages